natgillin/translations-raw huggingface dataset:
Hydrochlorthiazids tilsyneladende fordelingsvolumen er ca. 0,8 l/kg. 
The apparent volume of distribution is approximately 0.8 l/kg.
• Unormal hjerterytme (puls). 
Abnormal heart beat.
På grund af risikoen for nedsat plasmavolumen og hypoperfusion af placenta bør hydrochlorthiazid kun anvendes til gestationelt ødem, gestationel hypertension eller præeklampsi ved en gunstig effekt på sygdomsforløbet. 
Hydrochlorothiazide should not be used for gestational oedema, gestational hypertension or preeclampsia due to the risk of decreased plasma volume and placental hypoperfusion, without a beneficial effect on the course of the disease.
Anoreksi, appetitløshed, gastrisk irritation, diarré, forstoppelse Sjælden Pankreatitis 
Uncommon Anorexia, loss of appetite, gastric irritation, diarrhoea, constipation
Hvis du har taget for mange Atacand Plus Kontakt straks lægen eller apoteket, hvis du har taget flere Atacand Plus, end din læge har foreskrevet. 
If you take more Atacand Plus than you should If you take more Atacand Plus than prescribed by your doctor, contact a doctor or pharmacist immediately for advice.
- hvis du har/har haft en sygdom, som kaldes systemisk lupus erythematosus (SLE). 
you have ever had a disease called systemic lupus erythaematosus (SLE) you have low blood pressure you have ever had a stroke.
Sjælden Icterus (intrahepatisk kolestatisk icterus) 
Jaundice (intrahepatic cholestatic jaundice)
- hvis du er mere end 3 måneder henne i din graviditet (det er også bedst at undgå Atacand 
you are more than 3 months pregnant (it is also better to avoid Atacand Plus in early pregnancy - see pregnancy section).
• Heparin (blodfortyndende medicin). 
Heparin (a medicine for thinning the blood)
Thiaziddiuretika øger urinsyrekoncentrationen i serum og kan forårsage arthritis urica hos disponerede patienter. 
Thiazide diuretics increase serum uric acid concentration and may precipitate gout in susceptible patients.
• Påvirkning af nyrefunktionen, specielt hvis du allerede har nyreproblemer eller hjertesvigt. 
Effects on how your kidneys work, especially if you have kidney problems or heart failure.
Begge stoffer nedsætter dit blodtryk. 
These work together to lower your blood pressure.
Candesartan fremkaldte effekter på nyrerne (såsom regenerering, dilatation og øget tilstedeværelse af basofile granulocytter i tubuli; øget plasmakoncentration af urinstof og kreatinin). 
Effects on the kidneys (such as regeneration, dilatation and basophilia in tubules; increased plasma concentrations of urea and creatinine) were induced by candesartan which could be secondary to the hypotensive effect leading to alterations of renal perfusion.
Farmakoterapeutisk klassifikation: Angiotensin II-antagonister + diuretika, ATC-kode: C09DA06 Angiotensin II er det primære vasoaktive hormon i renin-angiotensin-aldosteron-systemet og spiller en rolle i patofysiologien for hypertension og andre kardiovaskulære sygdomme. 
Angiotensin II is the primary vasoactive hormone of the renin-angiotensin-aldosterone system and plays a role in the pathophysiology of hypertension and other cardiovascular disorders.
• Forbigående uklart syn. 
Blurred vision for a short time.
pneumonitis og lungeødem) 
Respiratory distress (including pneumonitis and pulmonary oedema)
Tal med din læge, hvis du er usikker på, om dette gælder for dig. 
If you are not sure if this applies to you, please ask your doctor.
Hvis det er stærkt nedsat, kan du eventuelt mærke træthed, svaghedsfølelse, uregelmæssig hjerterytme (puls) eller en prikkende/sovende fornemmelse på kroppen. 
If this is severe, you may notice tiredness, weakness, irregular heartbear or pins and needles.
- hvis du har en alvorlig nyresygdom. 
you have severe kidney problems.
Hvis noget af ovenstående gælder for dig, vil din læge eventuelt se dig oftere og tage nogle prøver. 
Your doctor may want to see you more often and do some tests if you have any of these conditions.
Hydrochlorthiazid kan forstærke virkningen af ikke-depolariserende muskelrelaksantia (f.eks. tubocurarin). 
The effect of nondepolarising skeletal muscle relaxants (e.g. tubocurarine) may be potentiated by hydrochlorothiazide.
Atacand Plus bør derfor ikke anvendes til denne patientgruppe. 
Therefore the use of Atacand Plus is not recommended in this population.
Andre bivirkninger inkluderer: Almindelig (forekommer hos mellem 1 og 10 ud af 100 patienter) 
Other possible side effects include: Common (affects 1 to 10 users in 100) Changes in blood test results: A reduced amount of sodium in your blood.
Kontakt din læge, før du tager dette lægemiddel, hvis lægen har fortalt dig, at du ikke tåler visse sukkerarter. 
If you have been told by doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Colestipol og colestyramin reducerer absorptionen af hydrochlorthiazid. 
The absorption of hydrochlorothiazide is reduced by colestipol or cholestyramine.
• Candesartan kan ikke fjernes ved hæmodialyse. 
Candesartan can not be removed by haemodialysis.
Det skal du vide, før du begynder at tage Atacand Plus Sådan skal du tage Atacand Plus Bivirkninger 
What Atacand Plus is and what it is used for Before you take Atacand Plus How to take Atacand Plus Possible side effects
og serum-kreatinin 
Increases in BUN and serum creatinine
ÆSKE TIL BLISTERKORT / ÆSKE TIL MEDICINGLAS / ETIKET TIL MEDICINGLAS 
PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING CARTON FOR BLISTER / CARTON FOR BOTTLE / LABEL FOR BOTTLE
Almindelig Hyperglykæmi, hyperurikæmi, elektrolytforstyrrelser (inkl. 
Common Hyperglycaemia, hyperuricaemia, electrolyte imbalance (including hyponatraemia and hypokalaemia)
Hos patienter, hvis kartonus og nyrefunktion overvejende afhænger af renin-angiotensinaldosteron-systemets aktivitet (for eksempel patienter med alvorlig hjerteinsufficiens eller underliggende nyresygdom, inkl. 
In patients whose vascular tone and renal function depend predominantly on the activity of the reninangiotensin-aldosterone system (e.g. patients with severe congestive heart failure or underlying renal disease, including renal artery stenosis), treatment with medicinal products that affect this system including AIIRAs, has been associated with acute hypotension, azotaemia, oliguria or, rarely, acute renal failure.
• Non-steroide antiinflammatoriske midler (NSAID'er) såsom ibuprofen, naproxen, diclofenac, 
Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, diclofenac, celecoxib or etoricoxib (medicines to relieve pain and inflammation).
Thiazider kan forstærke den hyperglykæmiske effekt af betablokkere og diazoxid. 
The hyperglycaemic effect of beta-blockers and diazoxide may be enhanced by thiazides.
• vanskelighed ved at trække vejret med eller uden hævelse af ansigt, læber, tunge, svælg og/eller hals. 
Stop taking Atacand Plus and seek medical help immediately if you have any of the following allergic reactions: difficulties in breathing, with or without swelling of the face, lips, tongue and/or throat.
Atacand Plus bør ikke anvendes under amning. 
The use of Atacand Plus during breast-feeding is not recommended.
Knogler, led, muskler og bindevæv 
Back pain, pain in joints and muscles.
• Muskelkramper. 
Laxatives.
SÅDAN SKAL DU TAGE ATACAND PLUS 
HOW TO TAKE ATACAND PLUS
DET SKAL DU VIDE, FØR DU BEGYNDER AT TAGE ATACAND PLUS 
BEFORE YOU TAKE ATACAND PLUS
Almindelig Stigning i kolesterol og triglycerider Sjælden Stigning i blod-urinstof-nitrogen (BUN) 
Common Increases in cholesterol and triglycerides
træthed, at din hud eller det hvide i dine øjne får en gullig farve og influenzalignende symptomer. 
Changes in how your liver is working, including inflammation of the liver (hepatitis).You may notice tiredness, yellowing of your skin and the whites of your eyes and flu like symptoms.
Anden behandling med bedre fastslået sikkerhedsprofil under amning bør foretrækkes, specielt ved amning af nyfødte eller for tidligt fødte børn. 
Because no information is available regarding the use of Atacand Plus during breastfeeding, Atacand Plus is not recommended and alternative treatments with better established safety profiles during breast-feeding are preferable, especially while nursing a newborn or preterm infant.
6.1 Hjælpestoffer [Udfyldes nationalt] 
6.3 Shelf life [To be completed nationally]
Hyppighed Bivirkning Luftveje, thorax og mediastinum Sjælden Åndedrætsbesvær (inkl. 
Respiratory, thoracic and mediastinal disorders
• Hududslæt, nældefeber, udslæt på grund af øget følsomhed for sollys. 
Skin rash, lumpy rash (hives), rash caused by sensitivity to sunlight.
Ortostatisk hypotension 
Hepatobiliary disorders
Dosering 
Pancreatitis
Hjerte 
Name
Stærkt nedsat nyrefunktion (kreatininclearance < 30 ml/min/1,73 m 
Second and third trimesters of pregnancy (see sections 4.4 and 4.6) Severe renal impairment (creatinine clearance < 30 ml/min/1.73 m2 BSA).
- Tal med lægen eller apoteket, hvis en bivirkning bliver alvorlig, eller du får bivirkninger, som ikke er nævnt her. 
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Sjælden Arytmier 
Very rare Cough
Almindelig Glukosuri Sjælden Nyreinsufficiens og interstitiel nyrebetændelse 
Musculoskeletal and connective tissue disorders
Mave-tarm-kanalen 
Muscle spasm
Kvalme 
Fever
Angioødem, udslæt, nældefeber, kløe 
Very rare Angioedema, rash, urticaria, pruritus
1 Inkluderer andre mindre almindelige eller ukendte arter 
1 Includes other less common species or species unknown
Dato for åbning:___________ 
Opening date:_________
- hvis du har eller nogensinde har haft problemer med leveren. 
- if you have or have ever had liver problems.
MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE) EU/1/19/1380/001 
MARKETING AUTHORISATION NUMBER(S) EU/1/19/1380/001
Fixed-time periodec 
Fixed-time periodc
FLU/ITZ (1899); FLU (316). 
a: FLU/ITZ (1899); FLU (316).
- Hvis det imidlertid næsten er tid for din næste dosis så tag din dosis til tiden. 
However, if it is almost time for your next dose, take your dose when it is due.
- Du må ikke tage en dobbeltdosis som erstatning for den glemte dosis. 
Do not take a double dose to make up for a forgotten dose.
Dette var imidlertid ikke et prospektivt randomiseret kontrolleret studie, og alle sammenligninger med den eksterne kontrolgruppe skal vurderes med forsigtighed. 
However, this was not a prospective, randomised controlled study and so all comparisons with the external control group should be viewed with caution.
08039 Barcelona Spanien 
08039 Barcelona, Spain
Efter første åbning af beholderen: 30 dage 
After first opening the container: 30 days
Eliminationshalveringstiden (t1/2) blev forlænget fra ca. 27 timer op til ~43 timer i de respektive grupper. 
The elimination half-life (t1/2) was prolonged from approximately 27 hours up to ~43 hours in respective groups.
- hvis du udvikler alvorlig diarré eller kaster op, da disse forhold kan begrænse virkningen af dette lægemiddel. 
- if you develop severe diarrhoea or vomiting, as these conditions may limit the effectiveness of this medicine.
Flasker, der viser nogen synlig sedimentering, skal omrystes kraftigt i mindst 10 sekunder. 
Bottles showing any visible settling should be vigorously shaken for a minimum of 10 seconds.
Virkning af posaconazol på andre lægemidler 
Effects of posaconazole on other medicinal products
Anbefalet dosering efter indikation Indikation 
Recommended dose according to indication.
H-1045 Budapest UNGARN 
H-1045 Budapest Hungary
Generelt syntes eksponeringen at være højre hos ældre patienter (7 til <18 år) end hos yngre patienter (2 til <7 år). 
In general, exposures tended to be higher in the older patients (7 to <18 years) than in younger patients (2 to <7 years).
Inden for systemorganklasserne er bivirkningerne anført under overskrifter for hyppighed ved brug af følgende kategorier: meget almindelig (≥1/10); almindelig (≥1/100 til <1/10); ikke almindelig (≥1/1.000 til <1/100); sjælden (≥1/10.000 til <1/1.000); meget sjælden (<1/10.000); ikke kendt. 
Tabulated list of adverse reactions Within the organ system classes, adverse reactions are listed under headings of frequency using the following categories: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥ 1/10,000 to <1/1,000); very rare (<1/10,000); not known.
Brug til børn Posaconazole AHCL må ikke anvendes til børn (17 år eller yngre). 
Children Posaconazole AHCL should not be used in children (17 years of age and younger).
fluconazol, itaconazol eller voriconazol. 
fluconazole, itraconazole or voriconazole.
Du må ikke selv tilpasse din dosis eller ændre din behandling, før du har talt med din læge. 
Do not adapt your dose yourself before consulting your doctor or change your treatment regime.
Chromoblastomykose/Mycetoma 
Chromoblastomycosis/Mycetoma
Farmakokinetiske modeller med en oral tabletformulering tyder på, at patienter, der vejer mere end 120 kg, kan have lavere eksponering for posaconazol. 
Pharmacokinetic modeling with an oral tablet formulation suggests that patients weighing greater than 120 kg may have lower posaconazole exposure.
d: Alle randomiserede patienter e: 
d: All randomized e: All treated
Hvis du 30 dage efter åbning af flasken har en rest af suspensionen tilbage, må du ikke anvende denne medicinrest. 
- If you have any suspension left in a bottle more than 30 days after it was first opened, you should not use this medicine.
Størstedelen (377/600, [63 %]) af de inkluderede patienter havde akut grad 2 eller 3 eller kronisk ekstensiv GVHD (195/600, [32,5 %]) ved studiestart. 
The majority (377/600, [63 %]) of patients included had Acute Grade 2 or 3 or chronic extensive (195/600, [32.5%]) GVHD at study start.
Epidemiologiske cut-off (ECOFF) -værdier for Aspergillus-arter. 
Epidemiological Cut-off (ECOFF) Values for Aspergillus spp.
Patienter med en lav kropsvægt (<60 kg) har større sandsynlighed for at opleve højere plasmakoncentration af posaconazol og bør monitoreres nøje for bivirkninger. 
Patients with a low body weight (< 60 kg) are more likely to experience higher plasma concentrations of posaconazole and should be closely monitored for adverse events.
EXP Kasseres 30 dage efter åbning. 
EXP Discard after 30 days of opening.
H-1045 Budapest 
H-1045 Budapest HUNGARY
I begge de profylaksiske studier var udbrud af aspergillose den hyppigste infektion. 
In both prophylaxis studies, aspergillosis was the most common breakthrough infection.
Baseret på KaplanMeier-estimater, var sandsynligheden for at overleve frem til dag 100 efter randomisering signifikant højere for modtagere af posaconazol; denne overlevelsesfordel blev påvist, da analysen betragtede død af alle årsager (P=0,0354) såvel som dødsfald med relation til IFI-relateret (P=0,0209). 
Based on Kaplan-Meier estimates, the probability of survival up to day 100 after randomization, was significantly higher for posaconazole recipients; this survival benefit was demonstrated when the analysis considered all causes of death (P= 0.0354) as well as IFI-related deaths (P = 0.0209).
Din læge vil følge virkningen og din tilstand for at bestemme, hvor længe Posaconazole AHCL skal tages, og om det er nødvendigt at ændre din daglige dosis. 
Your doctor will monitor your response and condition to determine how long Posaconazole AHCL needs to be given and whether any change is needed to your daily dose.
Refraktære invasive svampeinfektioner (IFI)/patienter med IFI som er intolerante over for førstevalgsbehandling 
Refractory invasive fungal infections (IFI)/patients with IFI intolerant to 1st line therapy
- infektioner i munden eller svælget (kendt som trøske) forårsaget af svampe kaldet Candida, som ikke er behandlet tidligere. 
- infections in the mouth or throat area (known as “thrush”) caused by fungi called Candida, which were not previously treated.
Samlet respons Virkning per art Alle mykologisk bekræftet Aspergillus arter1 
Overall Response Success by Species All mycologically confirmed Aspergillus spp.1
LISTE OVER HJÆLPESTOFFER Indeholder glukose. 
LIST OF EXCIPIENTS Contains glucose.
Klinisk succesrate blev defineret som antal forsøgspersoner vurderet som havende et klinisk respons (helbredelse eller forbedring) delt med det totale antal forsøgspersoner kvalificeret til analyse. 
Clinical success rate was defined as the number of cases assessed as having a clinical response (cure or improvement) divided by the total number of cases eligible for analysis
Hvis disse lægemidler administreres samtidigt, anbefales omhyggelig monitorering af fuldstændigt blodtælling og bivirkninger relateret til forhøjede niveaue af rifabutin (f.eks. uveitis). 
If these medicinal products are co-administered, careful monitoring of full blood counts and adverse reactions related to increased rifabutin levels (e.g. uveitis) is recommended.
Der er fundet korrelation imellem den totale eksponering af lægemiddel divideret med MIC (AUC/MIC) og den kliniske virkning. 
Pharmacokinetic / Pharmacodynamic relationships A correlation between total medicinal product exposure divided by MIC (AUC/MIC) and clinical outcome was observed.
Du kan føle dig svimmel, søvnig eller få sløret syn, mens du tager Posaconazole AHCL, hvilket kan påvirke din evne til at køre bil, bruge værktøj eller betjene maskiner. 
You may feel dizzy, sleepy, or have blurred vision while taking Posaconazole AHCL, which may affect your ability to drive or use tools or machines.
Tag ikke Posaconazole AHCL: - hvis du er allergisk over for posaconazol eller et af de øvrige indholdsstoffer i dette lægemiddel (angivet i punkt 6). 
Do not take Posaconazole AHCL - if you are allergic to posaconazole or any of the other ingredients of this medicine (listed in section 6).
EUCAST ECOFF-værdier: - Aspergillus flavus: 0,5 mg/l - Aspergillus fumigatus: 0,25 mg/l - Aspergillus nidulans: 0,5 mg/l - Aspergillus niger: 0,5 mg/l - Aspergillus terreus: 0,25 mg/l 
EUCAST ECOFF values: - Aspergillus flavus: 0.5 mg/L - Aspergillus fumigatus: 0.25 mg/L - Aspergillus nidulans: 0.5 mg/L - Aspergillus niger: 0.5 mg/L - Aspergillus terreus: 0.25 mg/L
Posaconazol-tabletter er den foretrukne formulering til optimering af plasmakoncentrationer, og de giver generelt højere lægemiddeleksponering i plasma end posaconazol oral suspension. 
Posaconazole tablets are the preferred formulation to optimize plasma concentrations and generally provide higher plasma drug exposures than posaconazole oral suspension.
I 1899, var det perioden fra randomisering til 100 dage efter randomisering; i 316 var det perioden fra baseline-dagen til 111 dage efter baseline. 
c: In 1899, this was the period from randomization to 100 days post-randomization; in 316 it was the period from the baseline day to 111 days post-baseline.
Posaconazol absorberes langsomt og elimineres langsomt med et stort tilsyneladende fordelingsvolumen (1.774 liter), og proteinbindingen, hovedsagelig til serum albumin, er høj (> 98 %). 
Posaconazole is slowly absorbed and slowly eliminated with a large apparent volume of distribution (1,774 litres) and is highly protein bound (> 98 %), predominantly to serum albumin.
- efavirenz og fosamprenavir, der anvendes til behandling af hiv-infektion. 
- efavirenz and fosamprenavir used to treat HIV infection.
Den fyldte og forseglede flaske er pakket i karton med en måleske af polystyren (2,5 ml og 5 ml) til opmåling og indgivelse af suspensionen. 
The filled and sealed bottle is packed into a carton along with a graduated polystyrene spoon (2.5 mL and 5 mL) for dispensing and administration of the suspension.
Posaconazols indvirkning på niveauet af fosamprenavir, når fosamprenavir gives sammen med ritonavir, er ikke kendt. 
The effect of posaconazole on fosamprenavir levels when fosamprenavir is given with ritonavir is unknown.
Du må ikke tage Posaconazole AHCL, hvis noget af ovenstående gælder for dig. 
Do not take Posaconazole AHCL if any of the above apply to you.
Posaconazols sikkerhed og virkning hos børn under 18 år er ikke klarlagt. 
The safety and efficacy of posaconazole in children aged below 18 years have not been established.
P-Værdi Andel af patienter (%) med verificeret/sandsynlig IFI On-treatment periodeb 
Proportion (%) of patients with proven/probable IFIs On-treatment periodb
Der er ingen klinisk erfaring som vurderer posaconazols indflydelse på fertiliteten hos mennesker. 
There is no clinical experience assessing the impact of posaconazole on fertility in humans.
Hvis samtidig administration er nødvendig, tilrådes nøje monitorering for tilbagevendende svampeinfektionen. 
If concomitant administration is required, close monitoring for breakthrough fungal infections is recommended.
Du må ikke skifte mellem posaconazol-tabletter og posaconazol oral suspension uden først at tale med lægen eller apotekspersonalet, da dette kan medføre manglende virkning eller øge risikoen for bivirkninger. 
Do not switch between taking Posaconazole tablets and posaconazole oral suspension without talking to your doctor or pharmacist because it may result in a lack of efficacy or an increased risk of adverse reactions.
Følgende lægemidler kan nedsætte virkningen af Posaconazole AHCL ved at nedsætte mængden af Posaconazole AHCL i blodet: - rifabutin og rifampicin (anvendes til behandling af visse infektioner). 
The following medicines may decrease the effectiveness of Posaconazole AHCL by decreasing the amount of Posaconazole AHCL in the blood: - rifabutin and rifampicin (used to treat certain infections).
Derfor kan posaconazol øge plasmakoncentrationen af digoxin så det er nødvendigt at monitorere digoxinniveauerne ved påbegyndelse eller seponering af behandling med posaconazol. 
Therefore, posaconazole may increase plasma concentration of digoxin and digoxin levels need to be monitored when initiating or discontinuing posaconazole treatment.
En stigning i Cmax (26 %) og AUC (29 %) kunne påvises i ældre (24 personer ≥65 år) i forhold til yngre (24 personer 18 - 45 år). 
Elderly (≥ 65 years) An increase in Cmax (26 %) and AUC (29 %) was observed in elderly subjects (24 subjects ≥ 65 years of age) relative to younger subjects (24 subjects 18 - 45 years of age).
Bivirkninger anført efter systemorganklasse og hyppighed* Blod og lymfesystem 
Adverse reactions by body system and frequency* Blood and lymphatic system disorders Common:
Macrogolglycerolhydroxystearat 
Macrogolglycerol hydroxystearate
Kontakt lægen, apotekspersonalet eller sundhedspersonalet, før du tager Posaconazole AHCL: - hvis du har haft en allergisk reaktion over for et andet svampemiddel såsom ketoconazol, 
Talk to your doctor or pharmacist before taking Posaconazole AHCL - if you have had an allergic reaction to another antifungal medicine such as ketoconazole,
Posaconazol findes også som 100 mg gastroresistente tabletter og 300 mg koncentrat til infusionsvæske, opløsning. 
Posaconazole is also available as 100 mg gastro-resistant tablet and 300 mg concentrate for solution for infusion.
Resultater fra kliniske studier til forebyggelse af invasive svampeinfektioner. 
Results from clinical studies in prophylaxis of Invasive Fungal Infections Study
DATO FOR ÆNDRING AF TEKSTEN Yderligere oplysninger om dette lægemiddel findes på Det Europæiske Lægemiddelagenturs hjemmeside http://www.ema.europa.eu 
Detailed information on this product is available on the website of the European Medicines Agency http://www.ema.europa.eu
Brug ikke Posaconazole AHCL under graviditet, medmindre det er foreskrevet af din læge. 
Do not take Posaconazole AHCL if you are pregnant unless you are told to by your doctor.
Et centralt sekundært endepunkt var forekomsten af verificeret/sandsynlig IFI i ontreatment perioden (fra første til sidste dosis studiemedicin + 7 dage). 
A key secondary endpoint was the incidence of proven/probable IFIs during the on-treatment period (first dose to last dose of study medicinal product + 7 days).
- lægemidler, der anvendes til at nedsætte mavesyre, herunder cimetidin og ranitidin eller omeprazol og lignende lægemidler, kaldet protonpumpehæmmere. 
- medicines used to decrease stomach acid such as cimetidine and ranitidine or omeprazole and similar medicines that are called proton pump inhibitors.